Jean-Yves has advised healthcare companies for 25 years. Jean-Yves graduated from HEC (89) and holds an MBA from INSEAD (96). Now Senior Healthcare director at Michel Dyens & Co. , an Investment bank based in New York and Paris with a focus on healthcare, upscale consumer goods and internet / media. Previously, he was Senior Healthcare Adviser at Bryan, Garnier and prior to this headed the European Healthcare Team at Cowen, based in London and reinforced Cowen’s Healthcare franchise in Europe. From 2003 to 2007, Jean-Yves led Boehringer Ingelheim's M&A department at their German headquarters and gained valuable expertise in corporate M&A execution and Board interaction. He joined Deutsche Bank in 1996 in Frankfurt and developed a sector specialization in Healthcare, from 2000 to 2003, he was based in Baltimore (MD, USA), responsible for spearheading the development of biotech M&A cross border execution franchise. Jean-Yves heads the the Healthcare Group at Michel Dyens & Co, a Franco-American Investment Banking Boutique focused on Healthcare, Luxury and Beauty. His Group covers a comprehensive array of corporate Investment Banking cross-border M&A, Capital Raising and Partnership assignments in the Specialty Pharma, Generics and OTC, biopharma/biotech, diagnostics, vaccines, personalized medicine and medtech spaces. Jean-Yves has gained a leading edge and strong transactional expertise in Medical Aesthetics, Dermo-cosmetics and Energy-Based Device, Tissue Reengineering and Regenerative Medicine, Ophthalmology and immuno-biology sectors. He is a regular speaker for the Analytical Part of the IMCAS Paris World Industry Tribune, where he has presented on fundamental and valuation megatrends since 8 years and contributes a number of his other Analyses to a number of IMCAS Events around the world (IMCAS Asia in Taipei, Bali as well as IMCAS of the Americas in Cancun).